Belite Bio, Inc Depreciation
Belite Bio, Inc (BLTE) reported Depreciation of $172.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-03-31
| Period end | Depreciation 12 month |
|---|---|
| 2025-12-31 | $172.00K 20-F · filed 2026-03-31 |
| 2024-12-31 | $164.00K 20-F · filed 2026-03-31 |
| 2023-12-31 | $139.00K 20-F · filed 2026-03-31 |
| 2022-12-31 | $64.00K 20-F · filed 2025-03-17 |
| 2021-12-31 | $30.00K 20-F · filed 2024-03-12 |
| 2020-12-31 | $17.00K 20-F · filed 2023-03-31 |